Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01786577 · ClinicalTrials.gov registry record
Study To Analyze Memory/Thinking Problems In Older Adults After Surgery
A clinical trial of Post-Operative Cognitive Decline in Older Adults, sponsored by University of Florida.
- Completed
- Registry status
- 147
- Enrollment target
- 1
- Study location
NCT01786577: Completed study of Post-Operative Cognitive Decline in Older Adults, sponsored by University of Florida.
NCT01786577 is a study of Post-Operative Cognitive Decline in Older Adults that has completed, run by University of Florida. The registered enrollment target is 147 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01786577, a study of Post-Operative Cognitive Decline in Older Adults, has completed, sponsored by University of Florida.
- COMPLETED
- Registry status
- 147 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of the study is to examine specific neuroimaging predictors of memory and executive decline in older adults at various stages after total knee replacement surgery.
Primary Outcome
Severity of pre-surgical/baseline neuroimaging markers of cerebrovascular disease will predict post-operative executive decline at 3 weeks, 3 months and 1 year.
Conditions Studied
Interventions
- OTHER Magnetic Resonance Imaging
- BEHAVIORAL Cognitive assessment testing
Study Locations (1)
Florida
- University of Florida - Gainesville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 147 participants |
| Start Date | 2013-03-19 |
| Est. Completion | 2018-07-21 |
What the finished NCT01786577 record still lists
NCT01786577 is an observational study that tracks outcomes without assigning an intervention. The registered 147 participants enrollment target is mid-sized for trials with a published cap.
The record links to 1 condition, with Post-Operative Cognitive Decline in Older Adults appearing as the primary indexed condition, and to 2 interventions - of which Magnetic Resonance Imaging is the first listed.
NCT01786577 reports a single indexed study location in Florida.
Frequently Asked Questions
What is clinical trial NCT01786577 about?
NCT01786577 is a clinical study titled "Study To Analyze Memory/Thinking Problems In Older Adults After Surgery". The purpose of the study is to examine specific neuroimaging predictors of memory and executive decline in older adults at various stages after total knee replacement surgery.
What is the current status of trial NCT01786577?
This trial is currently completed. The enrollment target is 147 participants. The study started on 2013-03-19. Estimated completion is 2018-07-21.
What conditions does trial NCT01786577 study?
This clinical trial studies the following conditions: Post-Operative Cognitive Decline in Older Adults.
What interventions are being tested in trial NCT01786577?
The interventions under investigation include: Magnetic Resonance Imaging (OTHER), Cognitive assessment testing (BEHAVIORAL).
Who is sponsoring clinical trial NCT01786577?
This trial is sponsored by University of Florida, which has 1,106 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01786577 being conducted?
This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04396613 · 147 participants · NA
Wound Closure Techniques in Primary Spine Surgery
- NCT04851119 · 147 participants · Phase 1
Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors
- NCT05523947 · 147 participants · Phase 1
Clinical Trial of YH32367 in Patients With HER2 Positive Locally Advanced or Metastatic Solid Tumor
- NCT06121843 · 147 participants · Phase 1
A Study to Evaluate the Safety, Effectiveness and Tolerable Dose of Arlocabtagene Autoleucel (BMS-986393) in Novel Combinations in Participants With Relapsed and/or Refractory Multiple Myeloma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI